Archive for the ‘Stem Cell Clinic’ Category

Top Stem Cell Therapy Clinic in Vail & Denver, Colorado …

Stem Cell Clinic | Posted by admin
Sep 20 2017

Do you have an idea of the natural healing potential that is available in your body?

Read on to find out where your body stores these powerful stem cells.

Adult stem cells are found in the highest concentration in adipose (fat) tissue. In smaller concentrations, they are additionally found in your bone marrow. Beyond what is used for harvesting, stem cells are also found in blood, skin, muscles, and organs.

Adipose tissue provides the largest volume of adult stem cells (1,000 to 2,000 times the number of cells per volume found in bone marrow). Bone marrow provides some stem cells but more importantly provides a large volume of growth factors to aid in the repair process. In addition to adult stem cells, fat tissue also contains numerous other regenerative cells that are important to the healing process.

Stem cells derived from adipose fat tissue have been shown to be a much better source for the repair of cartilage degeneration and recent studies have demonstrated its superior ability to differentiate into cartilage.

There are some myths and misconceptions about stem cells and where the cells come from. Dr. Brandt has dedicated a blog post to the important topic.

Read this article:
Top Stem Cell Therapy Clinic in Vail & Denver, Colorado ...

Stem Cell Therapy – American Regenerative Clinic, Stem …

Stem Cell Clinic | Posted by admin
Sep 19 2017

Stem Cell Therapy employs the bodys own healing potential by isolating stem cells from one location of the body (fat tissue or bone marrow) and relocating them to an area of disease, injury, or inflammation. The main function of stem cells is to maintain and repair tissue. Stem Cell Therapy enhances this natural function by getting stem cells more directly to an area of need within the body. As soon, as stem cells get in there, they will grow to type of cells the body needs to be repaired. Stem cells have the unique ability to form many different types of tissue including bone, cartilage, muscle, etc. They are naturally anti-inflammatory, and can therefore help in the bodys own healing process and potentially reverse the effects of many diseases.

Some of the conditions currently being successfully treated include arthritis, sport related injuries, COPD, CHF, CAD, DM, auto-immune disease such as Lupus Erythematosus and Crohns disease, neurological disorders such as multiple sclerosis and Parkinson disease, spinal cord injuries, autism, critical limb ischemia, and many others.

American Regenerative Clinic will perform outpatient procedures using a process in which we isolate a patients own stem cells from either their own adipose (fat) tissue, or bone marrow. After mini-liposuction or bone marrow harvest from pelvic bone under local anesthesia, the patient tissue will be specially processed. Then immediately Isolated Stem Cells will be delivered to the same patient. Depending on nature of the disease, the cells may be injected into the joint, IV, intrathecal (lumbar puncture), intramuscular, or as a combination of above. The entire process will take just a few hours.

In many old injuries and degenerative diseases, a phenomenon called cellular depletion occurs. Because Prolotherapy and PRP rely on the bodys available repair cells locally, these two methods may produce little results. Prolotherapy starts repair process by mobilizing growth factors in the area via lengthy process of multiple injections. PRP brings them right away, but lacks bricks for repair. More advanced Stem Cell Therapy delivers everything the body needs for promising treatment.

Please read the instructions below carefully.

Discontinue Anti-Inflammatory medication (Advil, Motrin, Ibuprofen, Aleve, and Aspirin) at least 3-4 days before your procedure. Discontinue any blood thinners or any herbs, supplements or vitamins 1-2 weeks before your procedure. Discontinue Systemic Steroids (Prednisone, Hydrocortisone, etc.) 1-2 weeks before your procedure. Steroid Injections (cortisone) should be discontinued at least 1 month before your procedure. Eat a light, healthy breakfast the day of your procedure. Drink plenty of water, especially the day of your procedure.

If you have any questions, you are welcome to call our office at 248-876-4242.

Please read the following steps carefully.

0-3 Days Post Stem Cell Therapy: It is highly recommended that the patient rest the day of the procedure. The next two days the patient should focus on keeping the affected joint(s) immobilized. We strongly encourage you to use connective tissue support vitamins and/or cream. It is imperative that you take this as directed by the doctor; this will enhance the healing process. Ice can be applied to the area of injection for 15-20 minutes, 3-4 times a day, for the first 48 hours. Mild to moderate post-procedure pain can happen. Significant post procedure pain will typically resolve during the first few days after the procedure. If you are experiencing post procedure pain, you can take Tylenol as needed. If necessary, pain medication will be prescribed during your visit. If antibiotics are prescribed, please take them as directed. They will only be prescribed if they are needed. DO NOT TAKE anti-inflammatory medications such as; Advil, Motrin, Ibuprofen, Aleve, and Aspirin, for at least 2 weeks after your procedure. DO NOT TAKE blood thinners or any herbs, supplements or vitamins 3-4 days after your procedure. DO NOT TAKE systemic steroids such as; Prednisone, Hydrocortisone, etc. for at least 2 weeks following your procedure. Do not take hot baths or go to saunas during the first few days following your procedure. Avoid showering for 24 hours following your procedure. Do not consume alcoholic beverages for the first 7 days following your procedure. Avoid smoking. Smoking delays healing and can increase the risk of complications. Drink at least 64 ounces of water daily to help your heal properly. Water does not mean tea, coffee, soda or juice. Wound Care: Keep the area clean, apply a dash antibiotic ointment and a Band-Aid to the post-harvest site. If you see signs of: excessive redness, swelling or experience excessive pain, please call us at 248.876.4242.

3-7 Days Post Stem Cell Therapy: At this point you should gradually start increasing your daily activities and increase your exercise. To maximize the effects of the procedure, proper exercise is necessary. If you are still experiencing pain, continue you can take Tylenol as needed. If prescribed antibiotics please continue to take them as directed. They will only be prescribed if they are needed. Continue to use the connective tissue support vitamins and/or cream to enhance healing. Continue to avoid alcohol for at least 7 days after your procedure. DO NOT TAKE systemic steroids such as; Prednisone, Hydrocortisone, etc. for at least 2 weeks following your procedure. DO NOT TAKE anti-inflammatory medications such as; Advil, Motrin, Ibuprofen, Aleve, and Aspirin, for at least 2 weeks after your procedure.

7 Days Post Stem Cell Therapy: A follow up appointment must be schedule for 1 week (7 days) after your procedure. During the follow up the doctor will assess your healing and determine the next best course of action. If sutures were placed, this will be the time when they will be removed.

1-4 Weeks Post Stem Cell Therapy: Continue to use the connective tissue support vitamins and/or cream to enhance healing. At this point after your procedure, we highly recommend starting physical therapy to aid you in the healing process and help you regain full range of motion to the affected joint(s). DO NOT TAKE systemic steroids such as; Prednisone, Hydrocortisone, etc. for at least 2 weeks following your procedure. DO NOT TAKE anti-inflammatory medications such as; Advil, Motrin, Ibuprofen, Aleve, and Aspirin, for at least 2 weeks after your procedure.

If you have any questions, at any time after your procedure, you are welcome to call our office at 248-876-4242.

Go here to read the rest:
Stem Cell Therapy - American Regenerative Clinic, Stem ...

Zika kills brain cancer cells, may find use as therapy – The San Diego Union-Tribune

Stem Cell Clinic | Posted by admin
Sep 05 2017

Zika, notorious for ravaging the brains of babies, could be useful in treating a particularly deadly brain cancer.

The virus kills glioblastoma stem cells, say researchers at UC San Diego and Washington University in St. Louis. They tested in human cell cultures and a mouse model of the disease

Moreover, Zika largely spared mature brain cells, the researchers say in a study published Tuesday in the Journal of Experimental Medicine.

People with glioblastoma rarely survive more than two years, although survival rates vary according to age and how aggressive the tumor is.

Study authors suggest a tamed version of the virus could be used along with other treatment to improve survival rates.

U.S. Senator John McCain was recently diagnosed with glioblastoma. The disease killed U.S. Senator Ted Kennedy, singer-actress Ethel Merman and retired baseball player Gary Carter.

Glioblastomas are treated with surgery, followed by radiation and chemotherapy. However, it is impossible to remove all the cancer without also removing healthy tissue and risking brain damage. So the cancer nearly always comes back.

Cancer stem cells cause the recurring tumors. These cells bear strong genetic resemblances to normal stem cells, and can proliferate greatly. Just one cell can regrow an entire tumor.

Glioblastoma stem cells also resist chemotherapy and radiation. But because they are stem cells, they are vulnerable to Zika. The virus causes an abnormally small head, or microcephaly, by destroying immature neural cells.

The study authors say a modified Zika virus could be applied after surgery, penetrating to the remaining cancer cells and killing them. One author, Jeremy Rich, M.D., is a renowned brain cancer specialist who recently joined UC San Diego from Cleveland Clinic. The first author, Zhe Zhu, also researches at UCSD.

Brain cancer specialists not involved with the study said by email it is scientifically sound, but there is a long way to go before it could be used in patients.

The science in this study is good considering the limitations of test tube and mice models, said Keith Black, M.D., chair of neurosurgery at Cedars-Sinai Medical Center in Los Angeles. What we don't know is how these results will translate to humans, given how different the complex human tumors are compared to simplistic mice models.

Before a Zika-based therapy can be tested in people, toxicity studies need to be completed in animals, along with regulatory approvals from the U.S. Food and Drug Administration and the institutes where the trial is to be conducted, Black said.

The approach has precedent in viral therapy by San Diegos Tocagen to treat glioblastoma, said Faith Barnett, M.D., a neurosurgeon with Scripps Green Hospital in La Jolla. Tocagens therapy is already being tested on glioblastoma patients. It uses poliovirus and retroviruses, a class of virus that includes HIV.

Whether Zika virus is a better vector needs to be determined, Barnett said. Clearly, we need creative approaches to improve current cancer therapies.

Unlike Zika, Tocagens viruses dont directly attack the brain cancer cells. Instead, they deliver a gene to the cancer that primes it for destruction when exposed to a drug precursor or prodrug.

The prodrug is converted into a toxic drug inside the cancer cells through an enzyme the gene codes for. Normal cells dont get the gene, and so are unaffected by the prodrug.

Go online to http://tocagen.com/patients for more information on Tocagens clinical trials.

For further reading

McCain completes round of radiation, chemo for brain cancer

UC San Diego hires renowned brain cancer expert Jeremy Rich

Blocking a tumor suppressor gene actually slows down one kind of glioblastoma

Survival time increases for those with deadly brain cancer: Study

Cancer genes hide outside chromosomes

Mom delays cancer care to protect baby she says saved her

Gary Carter to treat brain tumor with chemotherapy

Glioblastoma Anti-Angiogenesis Resistance Mechanism Found by Salk Researchers

bradley.fikes@sduniontribune.com

(619) 293-1020

Continued here:
Zika kills brain cancer cells, may find use as therapy - The San Diego Union-Tribune

FDA Reaffirms Its Commitment to the Approval of Stem Cell Therapies Amidst Enforcement Actions Against … – Lexology (registration)

Stem Cell Clinic | Posted by admin
Sep 05 2017

The U.S. Food and Drug Administration (FDA or Agency) has become increasingly active in stem cell and regenerative medicine product regulation within the past year previously announcing that it would release a modified framework for the regulation of these products in September. On August 28, FDA issued two news releases about recent enforcement actions taken against Florida and California stem cell companies and clinics, as well as a statement from FDA Commissioner Dr. Scott Gottlieb. Dr. Gottlieb noted the promise of adult stem cells as viable therapies with the appropriate testing and scientific evidence, and vowed to work with industry. He also, however, stated that the Agency would increase its enforcement activities against unscrupulous actors in this field.

On August 24, FDA issued a warning letter to U.S. Stem Cell Clinic, LLC in Sunrise, Florida. for violations of the Federal Food, Drug, and Cosmetic Act (FFDCA) namely, that the clinic (1) produced and administered unapproved stem cell treatments to patients; (2) violated current good manufacturing practices (cGMPs) and current good tissue practices (cGTPs); and (3) impeded FDAs inspection of the clinic. This same clinic was the subject of widespread stories in the popular press after publication of a New England Journal of Medicine article in March 2017 that reported varying degrees of vision loss in three patients who were treated with stem cells at the clinic. One day after FDAs news release about the warning letter, the clinic pushed back at the Agency by posting a public response and video.

On August 25, the U.S. Marshals Service seized non-commercial vials of live Vaccinia virus vaccine from StemImmune Inc. of San Diego, California. StemImmune allegedly used this vaccine, intended for very limited use against smallpox, to create an unapproved stem cell product by mixing the vaccine with stem cells and administering the product to cancer patients at the California Stem Cell Treatment Centers in Rancho Mirage and Beverly Hills, California. The U.S. Department of Justice filed the seizure complaint and warrant on behalf of FDA in the U.S. District Court for the Central District of California (Southern Division).

These two recent events prompted Commissioner Gottlieb to issue a statement on August 28 about the future of regenerative medicine regulation at FDA. Dr. Gottlieb acknowledged the small number of unscrupulous actors that risk tarnishing the regenerative medicine field as a whole, as well as the sincere reports of the significant clinical potential of properly developed products. While promising additional details in the coming months, Dr. Gottlieb announced the following:

Although FDA has not yet released the full scope of its plans, companies, clinics and physicians currently developing or using stem cell products must recognize that the Agency is committed to taking enforcement actions when necessary to protect the public health. Therefore:

Continue reading here:
FDA Reaffirms Its Commitment to the Approval of Stem Cell Therapies Amidst Enforcement Actions Against ... - Lexology (registration)

US FDA steps up enforcement against unscrupulous stem cell firms – BioPharma-Reporter.com

Stem Cell Clinic | Posted by admin
Sep 03 2017

The US FDA has warned a Florida-based clinic and seized vials of a smallpox vaccine in California used to create an unapproved product in a crackdown against "unscrupulous" stem cell firms.

Cell therapies are a new and emergent entity in the biopharma space, and last years 21st Century Cures Act looked to address industrys regulatory concerns by introducing the Regenerative Medicine Advanced Therapy (RMAT) designation offering personalised medicine makers anefficient development program for, and expedite review of, [their] drug if the drug qualifies as a regenerative advanced therapy.

But two separate enforcement actions in the past week have shown the abuse of such therapies within the US, and pushed the US Food and Drug Administration (FDA) to step up its regulation of the sector.

Stem cell clinics that mislead vulnerable patients into believing they are being given safe, effective treatments that are in full compliance with the law are dangerously exploiting consumers and putting their health at risk, FDA commissioner Scott Gottlieb said.

As the FDA takes new steps to advance an efficient, modern approach to the regulation of cell based regenerative medicine, at the same time we will be stepping up our enforcement actions against clinics that abuse the trust of patients and, more important, endanger their health with unsanitary conditions or by purporting to have treatments which may not provide any benefit.

Warning letter in Florida

US Stem Cell Clinic and its Chief Scientific Officer Kristin Comella received a warning letter for marketing its autologous stem cell products without FDA approval, as well as significantly deviating from current good manufacturing practice (cGMP) requirements in the manufacture of at least 256 lots.

The firm, located in Sunrise, Florida, claimed to offer stem cell treatments for a range of neurological, autoimmune, orthopaedic and degenerative diseases based on a patients own adipose tissue, which are processed into stromal vascular fraction (SVF) before being administered back into the patient.

However, the products are not the subject of an approved biologics license application (BLA) and have not demonstrated safety and efficacy. As such, the FDA said in a statement the company abused the trust of patients and put their health at risk and vowed to step up its vigilance against others offering unregulated stem cell treatment.

StemImmune and Smallpox

And yesterday the Agency announced it took action to stop the use of an unproven treatment developed by StemImmune Inc set to be administered to patients at the California Stem Cell Treatment Centers in Rancho Mirage and Beverly Hills, California.

Under the FDAs orders, five vials containing 100 does of the non-commercially available Vaccinia Virus Vaccine (Live) were seized by the US Marshals Service. The vaccine was intended for combination with stromal vascular fraction to create an unapproved stem cell product intended to be directly injected into cancer patients tumours.

The Agency said it investigating how StemImmune sourced the vaccine, which is reserved only for people at high risk for smallpox and is not commercially available.

Gottlieb also attacked the audacious but ultimately hollow claims made by these kinds of unscrupulous clinics or others selling so-called cures.

He added:The FDA will not allow deceitful actors to take advantage of vulnerable patients by purporting to have treatments or cures for serious diseases without any proof that they actually work. I especially wont allow cases such as this one to go unchallenged, where we have good medical reasons to believe these purported treatments can actually harm patients and make their conditions worse.

Furthermore, he pledged to vigorously investigate these kinds of unscrupulous clinics using the full range of our tools, be it regulatory enforcement or criminal investigations.

Excerpt from:
US FDA steps up enforcement against unscrupulous stem cell firms - BioPharma-Reporter.com

FDA Reaffirms Its Commitment to the Approval of Stem Cell Therapies Amidst Enforcement Actions Against … – JD Supra (press release)

Stem Cell Clinic | Posted by admin
Sep 03 2017

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:

Privacy Policy (Updated: October 8, 2015):

hide

JD Supra provides users with access to its legal industry publishing services (the "Service") through its website (the "Website") as well as through other sources. Our policies with regard to data collection and use of personal information of users of the Service, regardless of the manner in which users access the Service, and visitors to the Website are set forth in this statement ("Policy"). By using the Service, you signify your acceptance of this Policy.

JD Supra collects users' names, companies, titles, e-mail address and industry. JD Supra also tracks the pages that users visit, logs IP addresses and aggregates non-personally identifiable user data and browser type. This data is gathered using cookies and other technologies.

The information and data collected is used to authenticate users and to send notifications relating to the Service, including email alerts to which users have subscribed; to manage the Service and Website, to improve the Service and to customize the user's experience. This information is also provided to the authors of the content to give them insight into their readership and help them to improve their content, so that it is most useful for our users.

JD Supra does not sell, rent or otherwise provide your details to third parties, other than to the authors of the content on JD Supra.

If you prefer not to enable cookies, you may change your browser settings to disable cookies; however, please note that rejecting cookies while visiting the Website may result in certain parts of the Website not operating correctly or as efficiently as if cookies were allowed.

Users who opt in to receive emails may choose to no longer receive e-mail updates and newsletters by selecting the "opt-out of future email" option in the email they receive from JD Supra or in their JD Supra account management screen.

JD Supra takes reasonable precautions to insure that user information is kept private. We restrict access to user information to those individuals who reasonably need access to perform their job functions, such as our third party email service, customer service personnel and technical staff. However, please note that no method of transmitting or storing data is completely secure and we cannot guarantee the security of user information. Unauthorized entry or use, hardware or software failure, and other factors may compromise the security of user information at any time.

If you have reason to believe that your interaction with us is no longer secure, you must immediately notify us of the problem by contacting us at info@jdsupra.com. In the unlikely event that we believe that the security of your user information in our possession or control may have been compromised, we may seek to notify you of that development and, if so, will endeavor to do so as promptly as practicable under the circumstances.

Except as otherwise described in this privacy statement, JD Supra will not disclose personal information to any third party unless we believe that disclosure is necessary to: (1) comply with applicable laws; (2) respond to governmental inquiries or requests; (3) comply with valid legal process; (4) protect the rights, privacy, safety or property of JD Supra, users of the Service, Website visitors or the public; (5) permit us to pursue available remedies or limit the damages that we may sustain; and (6) enforce our Terms & Conditions of Use.

In the event there is a change in the corporate structure of JD Supra such as, but not limited to, merger, consolidation, sale, liquidation or transfer of substantial assets, JD Supra may, in its sole discretion, transfer, sell or assign information collected on and through the Service to one or more affiliated or unaffiliated third parties.

This Website and the Service may contain links to other websites. The operator of such other websites may collect information about you, including through cookies or other technologies. If you are using the Service through the Website and link to another site, you will leave the Website and this Policy will not apply to your use of and activity on those other sites. We encourage you to read the legal notices posted on those sites, including their privacy policies. We shall have no responsibility or liability for your visitation to, and the data collection and use practices of, such other sites. This Policy applies solely to the information collected in connection with your use of this Website and does not apply to any practices conducted offline or in connection with any other websites.

We reserve the right to change this Policy at any time. Please refer to the date at the top of this page to determine when this Policy was last revised. Any changes to our privacy policy will become effective upon posting of the revised policy on the Website. By continuing to use the Service or Website following such changes, you will be deemed to have agreed to such changes. If you do not agree with the terms of this Policy, as it may be amended from time to time, in whole or part, please do not continue using the Service or the Website.

If you have any questions about this privacy statement, the practices of this site, your dealings with this Web site, or if you would like to change any of the information you have provided to us, please contact us at: info@jdsupra.com.

- hide

Read more here:
FDA Reaffirms Its Commitment to the Approval of Stem Cell Therapies Amidst Enforcement Actions Against ... - JD Supra (press release)

Around the world – Bend Bulletin

Stem Cell Clinic | Posted by admin
Aug 29 2017

A-A+

Travel ban in the courts In the latest arguments over President Donald Trumps travel ban, a three-judge panel of a federal appeals court in Seattle indicated Monday it would continue allowing grandparents and other relatives of U.S. residents to travel to the U.S. from six predominantly Muslim countries. But the judges were less forthcoming about their views on exceptions to a second part of the ban, suspending the nations refugee program. In July in a provisional ruling, the Supreme Court allowed exceptions to the ban for many relatives but not for most refugees. The Supreme Court will hear arguments in the case in October.

Stem cell clinic crackdown The Food and Drug Administration announced a crackdown on dangerous stem cell clinics Monday, while pledging to ease the path to approval for companies and doctors with legitimate treatments in the field. The agency reported actions against two large stem cell clinics and a biotech company, saying it was critical to shut down unscrupulous actors in regenerative medicine, which includes stem cell and gene therapies and immunotherapies. Stem cells can develop into many different types of cells, and are thought to have the potential to repair or replace damaged tissue. But the FDA has approved only a few stem-cell products.

Trump timed Arpaio pardon for storm ratings President Donald Trump offered a fiery defense Monday of his decision to pardon former Arizona Sheriff Joe Arpaio as Hurricane Harvey made landfall in Texas last week and claimed he timed it to attract maximum attention as television viewers were glued to storm coverage. Trump also suggested the Justice Department had political motives during the Obama administration for charging the former sheriff in a case concerning his illegal profiling of Hispanics. Actually, in the middle of a hurricane, even though it was a Friday evening, I assumed the ratings would be far higher than they were normally, Trump said.

European migrant influx Measures intended to stop migrants from trying to cross the Mediterranean were at the center of discussions in Paris among four European leaders who met with the leaders of three African countries Monday. The meeting, billed as a minisummit, brought together the leaders of France, Germany, Italy and Spain as well as Chad and Niger and one of Libyas leaders. Chad and Niger are transit countries for people fleeing war or poverty, while Libya is a departure point for crossing the Mediterranean and a center for traffickers who promise to get people to Europe.

Kenyas strict plastic bag ban Kenya will now punish with up to four years in jail anyone making, selling or importing plastic bags, putting in place one of the worlds toughest bans on the ubiquitous item that is blamed for clogging oceans and killing marine life. The rule, announced in March and put into effect Monday, also means garbage bags will be taken off supermarket shelves and visitors entering Kenya will be required to leave duty-free shopping bags at the airport. Kenya joins more than 40 other countries including China, the Netherlands and France that have introduced taxes on bags or limited their use.

German nurse suspect in 86 deaths A German nurse serving a life sentence for murdering two of his patients is believed to have killed at least 86 people entrusted to his care, officials said Monday, in what they described as an imagination-defying series of crimes. The nurse, identified as Niels Hoegel, was sentenced to life in February 2015, after a court found him guilty of administering overdoses of heart medication to some patients in an intensive care ward where he worked from 1999 to 2001. He was convicted of two counts of murder, two counts of attempted murder and causing bodily harm to patients and is serving his sentence. During his trial, the former nurse confessed to intentionally inducing cardiac crises in 90 of his patients, 30 of whom he said had died. That prompted officials to launch an investigation into the deaths of some 130 of Hoegels former patients. The results were presented Monday in Oldenburg. Authorities are waiting for the results of 41 toxicology reports, the results of which could drive the number of confirmed deaths even higher

Indian guru rape sentencing An Indian court sentenced a well-known guru to at least 10 years in prison for rape Monday, three days after followers angered by his conviction engaged in violent protests. Gurmeet Ram Rahim Singh was found guilty Friday of having raped two women more than a decade ago. Thousands of Singhs followers had gathered in the state where the verdict was announced. They responded by smashing cars, setting fire to buildings and attacking police officers, and the violence later spread to other cities in northern India. At least 38 people were killed, and more than 250 were injured.

Border dispute in Asia India and China agreed Monday to back away from their confrontation over a tiny slice of territory high in the Himalayas, easing tensions between the worlds two most populous countries. Both sides agreed to give some ground in order to end the standoff. In a short statement, the Indian government said it had reached an understanding with Beijing. China seemed willing to compromise but still claims the territory.

18069661

Excerpt from:
Around the world - Bend Bulletin

Daily on Healthcare: Lack of bare counties doesn’t solve Obamacare’s problems – Washington Examiner

Stem Cell Clinic | Posted by admin
Aug 29 2017

SIGN UP! If youd like to continue receiving Washington Examiner's Daily on Healthcare newsletter, SUBSCRIBE HERE:http://newsletters.washingtonexaminer.com/newsletter/daily-on-healthcare/

Lack of bare counties doesnt solve Obamacares problems: Supporters of Obamacare have been celebrating that as of last week, every county will have at least one insurer offering plans on the exchange in 2018. Though that is better than a catastrophic scenario in which people in large swaths of the country do not have any options to buy insurance on the individual market, to celebrate this is to substantially move the goalposts for Obamacare. Even though there will be no bare counties, nearly a quarter of the counties will have only one insurer and nearly half of the counties will have a choice of two. That is a far cry from the way the law was sold as providing a wide array of options just like Orbitz or Expedia, but for health insurance. My guiding principle is, and always has been, that consumers do better when there is choice and competition, former President Barack Obama said in making the case for his healthcare law before a joint session of Congress in September 2009.

Costs still rising for consumers: Those who do not qualify for subsidies under Obamacare are facing significantly higher costs for their policies. And those whose current insurer isn't providing coverage for 2018, whether subsidized or not, likely will have to change doctors and hospitals to make sure they aren't slammed with high out-of-pocket medical expenses. The cutoff for when people have to pay full price is at a gross income of $48,240 a year for an individual and $98,400 for a family of four. For Carol Ray, 62, who lives in Arizona and whose gross income is $70,000 a year, premiums that she pays this year doubled to $1,182.78 a month. The bronze-level plan carries a $6,500 deductible for an individual or $13,100 for her and her husband. "I can write the check for it, so I guess you could say it's affordable," Ray said. "What I vacillate on is whether it's reasonable ... I'm not of unlimited funding ... At some point, I have to be pretty careful about what I'm spending.

Welcome to Philip Kleins Daily on Healthcare, compiled by Washington Examiner Managing Editor Philip Klein (@philipaklein), Senior Healthcare Writer Kimberly Leonard (@LeonardKL) and Healthcare Reporter Robert King (@rking_19). Email dailyonhealthcare@washingtonexaminer.com for tips, suggestions, calendar items and anything else. If a friend sent this to you and youd like to sign up, click here. If signing up doesnt work, shoot us an email and well add you to our list.

Sen. Dean Heller between a rock and a hard place: The Nevada Republican is confronting attacks over his votes on legislation to repeal Obamacare by touting his vote for a bill that was never supposed to become law. Heller, who is up for re-election in 2018 and is considered one of the most vulnerable Republicans, angered conservatives when he flip-flopped by voting against a bill that he voted for in 2015 that would have immediately gutted Obamacare without a replacement. He also faces attacks from his Democratic challenger, who says he went back on a promise to not strip healthcare away from millions of people. That has left the senator to defend a bill that many Republicans didn't want to become law: the "skinny" repeal bill that eliminated only Obamacare's individual and employer mandates and some of its taxes. Some Nevada political observers were confused by Heller's decision to vote for the skinny bill after voting down straight repeal and the Senate bill to repeal and replace Obamacare. "If you were going to write a guidebook on how not to handle an issue, Dean Heller has got one for you," said Jon Ralston, longtime political reporter and editor of the Nevada Independent, on KNPR's State of Nevada last month. "He could be a best-selling author: Don't do this.'"

Tom Price declares national emergency after Harvey: The Health and Human Services secretary declared a public health emergency in Texas as Hurricane Harvey made landfall Friday night. "HHS is taking the necessary measures and has mobilized the resources to provide immediate assistance to those affected by Hurricane Harvey," Price said in a statement posted to HHS.gov. Price has given the Centers for Medicare and Medicaid Services, Medicare beneficiaries and their healthcare providers more flexibility in meeting emergency healthcare needs.

Texas asks insurers to give flexibility to Harvey victims: Texas insurance regulator is calling on insurers to waive any penalties for people who get healthcare outside of their network.

The states insurance commissioner said Saturday that the storm could force enrollees to evacuate their residences and location where they normally get healthcare. Insurers should waive any penalties for going out of network as a result of the disaster, the state said. Harvey brought torrential rain and floods that have forced tens of thousands of people in Texas to flee their homes.

FDA cracks down on stem cell clinic: The Food and Drug Administration warned a Florida stem cell clinic for peddling unauthorized stem cell products. The warning letter issued Monday to U.S. Stem Cell Clinic in Sunrise, Fla., is part of a larger crackdown on fraudulent stem cell clinics. The warning letter from FDA Commissioner Scott Gottlieb found that the clinic manufactured products in unsanitary conditions and marketed products that werent reviewed or approved by the agency.

RUNDOWN

Axios What could happen next on Obamacares taxes

Washington Post In Trump states, Sanders tries to push Democrats to the left on healthcare

Bloomberg The FDAs consumer protection warnings are falling under Trump

Forbes Employer plans join Obamacare in narrowing doctor networks for 2018

STAT News Peter Thiel runs offshore test of herpes vaccine, bypassing U.S. safety regulations

New York Times Trumps threats on health law hide an upside: Gains made by some insurers

LA Times The debate over single payer isnt going away in California. Heres why

Minneapolis Star Tribune Measles outbreak was costly, state health officials say

Miami Herald Woman eats out of dumpster so her husband can afford healthcare

MONDAY , Aug. 28

Aug. 28-31. Paralyzed Veterans of America Annual Summit. Details.

WEDNESDAY, Aug. 30

1 p.m. Rural Health Information Hub, CDC and National Cancer Institute hold webinar on rural cancer. Details.

THURSDAY, AUG. 31

7 p.m., Rockville, Md. Maryland Sen. Ben Cardin holds a town hall to discuss healthcare at Johns Hopkins Universitys Rockville, Md., campus. 9601 Medical Drive. events2@cardin.senate.gov

WEDNESDAY, SEPT. 6

10 a.m. 430 Dirksen. The Senate Health, Education, Labor and Pensions Committee will hold a hearing on stabilizing the Obamacare exchanges. State insurance commissioners will testify.help.senate.gov/hearings/stabilizing-premiums-and-helping-individuals-in-the-individual-insurance-market-for-2018-state-insurance-commissioners

THURSDAY, SEPT. 7

9 a.m. 430 Dirksen. The Senate Health, Education, Labor and Pensions Committee will hold a second hearing on stabilizing the Obamacare exchanges, with several governors testifying. help.senate.gov/hearings/stabilizing-premiums-and-helping-individuals-in-the-individual-insurance-market-for-2018-governors

See more here:
Daily on Healthcare: Lack of bare counties doesn't solve Obamacare's problems - Washington Examiner

How a UCSF study could change the lives of babies in the womb and maybe help California’s stem cell program in … – San Francisco Business Times

Stem Cell Clinic | Posted by admin
Aug 25 2017
How a UCSF study could change the lives of babies in the womb and maybe help California's stem cell program in ...
San Francisco Business Times
The world's first in-utero blood stem cell transplant, soon to be performed at the University of California, San Francisco, could point the way toward pre-birth cures for a range of blood diseases, such as sickle cell disease. It's also the sort of ...

and more »

Originally posted here:
How a UCSF study could change the lives of babies in the womb and maybe help California's stem cell program in ... - San Francisco Business Times

Stem Cell Study for Dogs – MyWabashValley

Stem Cell Clinic | Posted by admin
Aug 23 2017

Terre Haute, IN - Maggie Mae and her owner Robert Howrey come from Paris, Illinois for a check-up at the Wabash Valley Animal Hospital in Terre Haute. She doesn't act like it, but Maggie Mae is a senior citizen and she has problems with her joints.

"Arthritis is a common condition in older dogs and we like to help them out," said Dr. Andrew Pickering, veterinarian.

A California company called "Animal Cell Therapies" has enlisted veterinarians all across the country to participate in a study of using stem cells for dogs with arthritis. Some of the canines in the study receive an injection of stem cells, others get just a saline solution.

Local vet, Doctor Andrew Pickering doesn't know which injections Maggie Mae is getting, but she no longer limps, and he's encouraged by the results.

"We're hoping this particular type of treatment will cure the condition for a long period of time so we don't have to keep giving the dog medication all the time," said Pickering.

Howrey says it's almost like having a new dog. "It's been about six weeks, so now she's back doing normal activities, she runs, she chases squirrels "

The research will continue for several more months. And the local clinic is still looking for owners who would like to get their pets involved. Study participation is free for dogs that qualify. Plus, even the animals that receive the saline injections will be able to get the stem cell treatment once the study is complete.

Click here to connect with the study web page

Click here to connect with the Wabash Valley Animal Hospital

View post:
Stem Cell Study for Dogs - MyWabashValley